Trial
NCT00833859
Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Sanofi
Condition
Pancreatic Neoplasms
Intervention
GTX (gemcitabine, docetaxel and capecitabine)
Why stopped
Abandoned - Lack of funding after only 2 patients enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-09